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Abstract
Background: Melioidosis, a lethal tropical infection that is endemic in southeast Asia and northern
Australia, is caused by the saprophytic Gram-negative bacterium Burkholderia pseudomallei. Overall
mortality approaches 40% yet little is known about mechanisms of host defense. Toll-like receptors
(TLRs) are host transmembrane receptors that recognize conserved pathogen molecular patterns
and induce an inflammatory response. The lipopolysaccharide (LPS) of Gram-negative bacteria is a
potent inducer of the host innate immune system. TLR4, in association with MD-2, is the archetype
receptor for LPS although B. pseudomallei LPS has been previously identified as a TLR2 agonist. We
examined TLR signaling induced by B. pseudomallei, B. pseudomallei LPS, and B. pseudomallei lipid A
using gain-of-function transfection assays of NF-κB activation and studies of TLR-deficient
macrophages.
Results: In HEK293 cells transfected with murine or human TLRs, CD14, and MD-2, heat-killed B.
pseudomallei activated TLR2 (in combination with TLR1 or TLR6) and TLR4. B. pseudomallei LPS and
lipid A activated TLR4 and this TLR4-mediated signaling required MD-2. In TLR2-/- macrophages,
stimulation with heat-killed B. pseudomallei augmented TNF-α and MIP-2 production whereas in
TLR4-/-  cells, TNF-α, MIP-2, and IL-10 production was reduced. Cytokine production by
macrophages stimulated with B. pseudomallei LPS or lipid A was entirely dependent on TLR4 but
was increased in the absence of TLR2. TLR adaptor molecule MyD88 strongly regulated TNF-α
production in response to heat-killed B. pseudomallei.
Conclusion: B. pseudomallei activates TLR2 and TLR4. In the presence of MD-2, B. pseudomallei
LPS and lipid A are TLR4 ligands. Although the macrophage cytokine response to B. pseudomallei
LPS or lipid A is completely dependent on TLR4, in TLR2-/- macrophages stimulated with B.
pseudomallei, B. pseudomallei LPS or lipid A, cytokine production is augmented. Other MyD88-
dependent signaling pathways may also be important in the host response to B. pseudomallei
infection. These findings provide new insights into critical mechanisms of host defense in
melioidosis.
Background
Melioidosis is an endemic and poorly understood infec-
tious disease in much of the tropical world; it is particu-
larly prevalent in east Asia and northern Australia. The
disease accounts for 20% of community-acquired sepsis
in parts of northeast Thailand. Despite antibiotic treat-
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ment, mortality rates approach 40% [1]. The causative
organism, Burkholderia pseudomallei (Bp), is a Gram-nega-
tive environmental saprophyte. Aerosol or transcutaneous
infection results in an extensive range of disease – from
chronic, relapsing illness with abscess formation to fulmi-
nant pneumonia and septicemia [2]. The lung is the most
commonly affected organ. Concern about the use of Bp as
a bioweapon has led to its classification as a CDC Cate-
gory B pathogen. While there are several known predis-
posing factors to clinical infection, such as diabetes, renal
or liver disease, alcoholism, or immunosuppression [3],
relatively little is known about mechanisms of host sus-
ceptibility.
Innate immune signaling mechanisms comprise the front
line of host defense against infection. Toll-like receptors
(TLRs) are transmembrane receptors in the IL-1 receptor
superfamily that are activated by conserved pathogen-
associated molecular patterns and result in nuclear tran-
scription factor (NF)-κB translocation and induction of a
pro-inflammatory response [4]. TLR2, in tandem with
TLR1 or TLR6, is activated by bacterial cell wall lipopep-
tides and peptidoglycan. TLR4, in association with pro-
teins CD14 and MD-2, recognizes the lipid A component
of lipopolysaccharide (LPS) of most Gram-negative
organisms. The importance of TLR2 and TLR4 in pulmo-
nary host defense has been well established [5-9].
As a Gram-negative bacterium, Bp has putative ligands for
both TLR2 and TLR4 [4]. Wiersinga et al. found increased
TLR2 and TLR4 expression and mRNA levels in monocytes
and granulocytes of humans with melioidosis as well as
activation of these TLRs by Bp in vitro [10]. Wiersinga et
al. also reported a protective phenotype in TLR2-deficient
mice infected intranasally with Bp. However, they unex-
pectedly observed that Bp LPS activates TLR2, not TLR4, in
transfected HEK293 cells.
In this study, we evaluated the roles of TLR2 and TLR4 in
melioidosis using TLR transfection constructs as well as
bone marrow-derived macrophages from TLR-deficient
mice. We report here that heat-killed Bp activates TLR2 in
conjunction with TLR1 or TLR6, as well as TLR4. We also
show that cytokine production induced by stimulation of
primary cells with heat-killed Bp is dependent on TLR4
but that cytokine release is augmented in the absence of
TLR2. We further demonstrate that Bp LPS and Bp lipid A
are ligands for TLR4, not TLR2.
Methods
Preparation of bacteria
Bp BP-1, a clinical isolate cultured from a liver abscess of
a Vietnamese patient presenting for medical care in Wash-
ington state, was grown for 19 hours at 37°C in LB broth.
Bacteria were washed twice in sterile PBS and resuspended
in PBS. The bacterial slurry was then heat-killed for 60
minutes at 65°C. Bacterial concentration and confirma-
tion of successful killing was determined by quantitative
culture on LB agar of the washed and heat-killed slurries,
respectively.
LPS and lipid A isolation and purification
Large-scale BP-1 LPS preparations were isolated using a
hot phenol/water extraction method after growth of BP-1
in LB supplemented with 1 mM MgCl2 at 37°C [11]. Sub-
sequently, LPS was treated with RNase A, DNase I and
proteinase K to ensure purity from contaminating nucleic
acids and proteins [12]. Reference strain Bp K96243 LPS
was kindly provided by Donald Woods at the University
of Calgary. BP-1 and K96243 LPS samples were addition-
ally extracted to remove contaminating phospholipids
[13] and TLR2 contaminating proteins [14,15]. LPS prep-
arations were determined to have less than 1% contami-
nating protein as determined by BCA reaction (Pierce,
Rockford, IL). Lipid A was isolated after hydrolysis in 1%
SDS at pH 4.5 as described [16]. Briefly, 500 μl of 1% SDS
in 10 mM Na-acetate, pH 4.5 was added to a lyophilized
sample. Samples were incubated at 100°C for 1 hour, fro-
zen, and lyophilized. The dried pellets were resuspended
in 100 μL of water and 1 mL of acidified ethanol (100 μL
4 N HCl in 20 mL 95% EtOH). Samples were centrifuged
at 5,000 rpm for five minutes. The lipid A pellet was fur-
ther washed three times in 1 mL of 95% EtOH. The entire
series of washes was repeated twice. Samples were resus-
pended in 500 μL of water, frozen on dry ice and lyophi-
lized. Before use, samples were resuspended in sterile
water. Finally, negative ion matrix-assisted laser desorp-
tion ionization time-of-flight (MALDI-TOF) mass spec-
trometry (MS) experiments were performed for the
analysis of lipid A preparations to profile structures
present in these preparations. Lyophilized lipid A was dis-
solved with 10 μL 5-chloro-2-mercaptobenzothiazole
(CMBT) (Sigma-Aldrich, St. Louis, MO) MALDI matrix in
chloroform/methanol, 1:1 (v/v), and then applied (1 μL)
onto the sample plate. All MALDI-TOF experiments were
performed using a Bruker Autoflex II MALDI-TOF mass
spectrometer (Bruker Daltonics Inc., Billerica, MA). Each
spectrum was an average of 200 shots. ES Tuning Mix
(Agilent, Palo Alto, CA) was used to calibrate the MALDI-
TOF MS.
HEK293 transfections and stimulations
HEK293 cells were cultured in a 96 well flat-bottomed tis-
sue culture plate at ~5 × 104 cells/well in DMEM plus 10%
FBS. The following day cells were transiently transfected
with 5 μL of transfection reagent comprised of a 1:1 mix
of 0.25 M CaCl2 containing 2 × BBS (50 mM BES, 280 mM
NaCl, and 1.5 mM NaH2PO4) and the following DNA:
NF-κB-dependent firefly ELAM luciferase and control β-
actin-dependent Renilla luciferase; and human or murineBMC Immunology 2008, 9:46 http://www.biomedcentral.com/1471-2172/9/46
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CD14, MD-2 (except as noted), with either TLR2, TLR2
and TLR1, TLR2 and TLR6, or TLR4 [17]. Two different
human TLR1 plasmids were transfected in conjunction
with TLR2, one with G at base pair 1805 (which yields
lower responses to Pam3CSK4) and one with T at this
position (which yields higher responses to Pam3CSK4)
[7]. DNA was added in the following amounts to each
well: hu- or muMD2 0.0025 μg, hu- or muCD-14 0.0025
μg, ELAM luciferase 0.01 μg, and Renilla luciferase 0.0003
μg. When transfected alone, the following amounts of
DNA were added: hu- or muTLR2 0.0025 μg, huTLR4
0.0025 μg, or muTLR4 0.0003 μg. When co-transfected
with TLR1 or TLR6, huTLR2 0.00125 μg or muTLR2
0.0025 μg was used in addition to huTLR1 0.00125 μg or
muTLR1 0.025 μg; or huTLR6 0.0125 μg or muTLR6
0.0025 μg. All transfections were normalized to 0.05 μg
total DNA with the addition of empty vector. Transfected
cells were washed once after four hours and were stimu-
lated the following day with experimental ligands, non-
specific stimulus recombinant human IL-1β (Pierce
Endogen, Rockford, IL), control TLR4 ligand ultrapure
Escherichia coli 0111:B4 LPS (Invivogen, San Diego, CA),
or control TLR2 ligand Pam3CSK4 (Invivogen and EMC
Microcollections, Tuebingen, Germany). After four hours,
cells were lysed with passive lysis buffer (Promega, Madi-
son, WI) and NF-κB activation was determined in 10 μL of
lysate by the ratio of firefly to Renilla luciferase light emis-
sion using the Dual Luciferase Reporter System (Promega,
Madison, WI).
Animals
Specific-pathogen-free C57BL/6 mice were obtained from
Jackson Laboratories (Bar Harbor, ME). TLR2-/-, TLR4-/-,
TLR2/4-/-, and MyD88-/- mice backcrossed at least six gen-
erations to C57BL/6 mice were obtained from Dr. Chris
Wilson at University of Washington. All animals were
housed in laminar flow cages and were permitted ad lib
access to sterile food and water. Euthanasia was accom-
plished with intraperitoneal pentobarbital followed by
exsanguination from cardiac puncture prior to bone mar-
row harvest. The Institutional Animal Care and Use Com-
mittee of the University of Washington approved all
experimental procedures.
Bone marrow-derived macrophage stimulations
Femurs and tibias were harvested under sterile conditions
from wild type, TLR-deficient, and MyD88-/- mice. Marrow
was flushed out using a 26 gauge needle through a 0.2 μm
strainer and cultured in Petri dishes in RPMI media sup-
plemented with 1% L-glutamine, 1% penicillin-strepto-
mycin, 10% fetal bovine serum and 20% L929 cell
conditioned media at 37°C under 5% CO2 for 5–10 days
to allow macrophages to predominate. The monolayer
was washed twice with HBSS or media, and macrophages
resuspended in RPMI media supplemented with 1% L-
glutamine, 1% HEPES, and 10% fetal bovine serum. Cells
were added to a 96 well flat-bottomed tissue culture plate
at 3 × 104 to 2 × 105 cells/well, depending on the experi-
ment. The following day, cells were stimulated with exper-
imental ligands, control TLR4 ligand ultrapure E. coli
0111:B4 LPS (Invivogen, San Diego, CA), or control TLR2
ligand Pam3CSK4 (Invivogen) in fresh media added to
each well. After stimulation for 24 hours, supernatants
were removed and stored at -80°C until assayed. TNF-α,
MIP-2, and IL-10 were quantified in the supernatants
using DuoSet ELISA (R&D Systems, Minneapolis, MN).
Statistical analyses
Comparisons between two groups of normally distributed
data were performed using the t test. Comparisons
between three or more groups of normally distributed
data were performed with analysis of variance followed by
the Bonferroni post-test between groups. Statistical testing
was undertaken using Stata v9.0 (StataCorp, College Sta-
tion, TX). Statistical significance was declared for two-
tailed p < 0.05.
Results
In order to identify TLRs that recognize Bp, HEK293 cells
transiently transfected with plasmids expressing murine
TLR2, TLR2/1, TLR2/6, or TLR4, and co-receptors CD14
and MD-2 were stimulated with a heat-killed Bp clinical
isolate BP-1 (Figure 1A). Using an NF-κB-dependent luci-
ferase reporter assay, strong Bp-induced NF-κB activation
was detected in TLR2- and TLR4-transfected cells with aug-
mentation of the TLR2-dependent signal in the presence
of TLR1 or TLR6. To determine whether similar signaling
is triggered by human receptors in response to Bp,
HEK293 cells transfected with plasmids expressing
human TLRs were also stimulated with Bp (Figure 1B).
TLR2- and TLR4-mediated NF-κB activation was observed
in a largely dose dependent fashion. Both TLR1 and TLR6
augmented the TLR2-mediated response. We also trans-
fected a hypo-responsive variant human TLR1 plasmid in
addition to TLR2 in this system and observed little ampli-
fication of the TLR2-dependent signal upon stimulation
with Bp (data not shown). Because MD-2 is a necessary
molecule for TLR4 signaling, human TLR4 transfection
was repeated without co-transfecting MD-2. In the
absence of MD-2, a TLR4-mediated signal in response to
Bp was not detected (Figure 1C) although TLR2-mediated
signaling was not altered (data not shown).
Since robust TLR4-dependent NF-κB activation was
observed using heat-killed Bp, we sought to identify which
Bp ligand activates TLR4 signaling. As Bp LPS was the most
likely candidate, LPS was isolated and purified from the
Bp clinical isolate BP-1. LPS from the Bp reference strain
K96243 was acquired and also purified. Moreover,
because lipid A is the specific component of LPS that acti-BMC Immunology 2008, 9:46 http://www.biomedcentral.com/1471-2172/9/46
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Figure 1
B. pseudomallei activates TLR2 and TLR4. HEK293 cells were transiently transfected with (A) murine or (B) human 
TLR2, TLR2/1, TLR2/6, or TLR4; co-receptors CD14 and MD-2; and NF-κB-dependent firefly ELAM luciferase and control β-
actin-dependent Renilla luciferase. In (C) HEK293 cells were transiently transfected with human TLR4 and co-receptor CD14 
with or without MD-2; and firefly ELAM and Renilla luciferases. Cells were stimulated with media alone, (B) IL-1β 20 ng/mL, (A 
& B) Pam3CSK4 100 ng/mL, E. coli 0111:B4 LPS 10 ng/mL, or heat-killed BP-1 at various concentrations in CFU/mL. NF-κB 
activation was measured by light emission (relative light units). In (A&B) data plotted are means ± standard deviations of trip-
licate conditions. In (C) the means ± standard deviations of triplicate human TLR4-mediated relative light units (normalized to 
mean empty vector values) are plotted from parallel experiments with or without co-transfection of MD-2. For (A & B) * indi-
cates p < 0.05 and § indicates p = 0.001 compared with empty vector stimulated with the same ligand, and † indicates p < 0.05 
compared with TLR2 stimulated with the same ligand using analysis of variance followed by the Bonferroni post-test. Other 
comparisons are not shown for clarity. The data in (A) represent one of two independently performed experiments. The data 
in (B) represent one of three independently performed experiments, but the data displayed, in contrast to the two other 
experiments, show the response to a hyper-responding variant TLR1 plasmid. The data in (C) represent one of three inde-
pendently performed experiments.
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vates TLR4, lipid A was isolated from BP-1. HEK293 cells
transiently transfected with murine or human TLR2,
TLR2/1, TR2/6, or TLR4, and co-receptors CD14 and MD-
2 were stimulated with these ligands (Figure 2A &2B). In
both murine- and human-transfected cells, robust TLR4-
dependent NF-κB activation was identified in response to
LPS from both Bp strains and in response to BP-1 lipid A
without evidence of TLR2 stimulation by these ligands.
Additionally, identical stimulations with Bp LPS and BP-1
lipid A of cells transfected with human TLR4 and CD14 in
the absence of MD-2 were performed, and no TLR4-medi-
ated NF-κB activation was observed (Figure 2C).
These observations in a transfected cell line prompted us
to examine the cytokine response to Bp and Bp LPS in pri-
mary cells. Therefore, bone marrow-derived macrophages
from wild type, TLR2-/-, TLR4-/-, and TLR2/4-/- mice were
stimulated with heat-killed BP-1, BP-1 LPS, K96243 LPS,
or BP-1 lipid A. Pro-inflammatory cytokine TNF-α was
quantified in cell supernatants by ELISA after 24 hours of
incubation (Figure 3A). Compared to wild type cells, TNF-
α production by TLR4-/- cells in response to BP-1 stimula-
tion was significantly reduced, but was completely elimi-
nated in response to BP-1 LPS, K96243 LPS, or BP-1 lipid
A. In TLR2-/- cells, however, TNF-α production after stim-
ulation with BP-1 was either the same as or greater than
that produced by wild type cells in several different exper-
iments (3.8 fold greater in the experiment shown). TLR2-/
- cells invariably produced more TNF-α than wild type
cells after stimulation with BP-1 LPS, K96243 LPS, or BP-
1 lipid A (1.4, 2.0, or 2.2 fold greater, respectively, in the
experiment shown). Furthermore, TLR2/4-/- cells demon-
strated only partial reduction in TNF-α production com-
pared to TLR4-/- cells stimulated with BP-1. Chemokine
MIP-2 was also measured in the supernatants of wild type,
TLR2-/-, TLR4-/-, and TLR2/4-/- cells stimulated with the
same ligands, and a similar pattern to TNF-α production
was observed (data not shown). A higher concentration of
Bp LPS than control Escherichia coli LPS was used in these
experiments because in a separate dose response experi-
ment stimulating wild type macrophages, both strains of
Bp LPS yielded several fold less TNF-α production than
similar concentrations of E. coli LPS (data not shown).
The findings indicating augmented pro-inflammatory
cytokine production in the absence of TLR2 when cells
were stimulated with Bp, Bp LPS, and Bp lipid A led us to
evaluate whether this was an IL-10-mediated phenome-
non. IL-10 is an anti-inflammatory cytokine that may be
released by cells upon TLR2 stimulation [18]. We there-
fore measured IL-10 in cell supernatants stimulated with
heat-killed BP-1, BP-1 LPS, K96243 LPS, or BP-1 lipid A
(Figure 3B). However, we did not identify any impairment
in IL-10 production by TLR2-/- cells in response to these
ligands. In general, the overall pattern of IL-10 production
was again similar to TNF-α production, with augmenta-
tion of BP-1 LPS-, K96243 LPS-, or BP-1 lipid A-induced
IL-10 release in the absence of TLR2.
As the TLR adaptor molecule myeloid differentiation fac-
tor 88 (MyD88) mediates both TLR2 and TLR4 signaling,
MyD88-/- bone marrow-derived macrophages were there-
fore stimulated with heat-killed BP-1 and cytokine pro-
duction assayed after 24 hours (Figure 4). Compared to
wild type cells, TNF-α production by MyD88-/- macro-
phages was markedly curtailed.
Discussion
In this report, we demonstrate that heat-killed Bp activates
TLR2 and TLR4. We further show that Bp LPS and Bp lipid
A are TLR4 ligands and we identify augmented macro-
phage cytokine production induced by Bp, Bp LPS or Bp
lipid A in the absence of TLR2.
TLRs are innate immune receptors that recognize con-
served pathogen motifs and initiate an inflammatory sig-
naling cascade. We and others have demonstrated the
essential roles of TLRs in host defense against a variety of
pulmonary pathogens [5-9]. TLR2 is a promiscuous recep-
tor that generally recognizes bacterial lipotechoic acid,
peptidoglycans, or lipoproteins and functions as a het-
erodimer with either TLR1 or TLR6 [19-22]. LPS is the pro-
totypical bacterial ligand for TLR4 [23] and is comprised
of a core polysaccharide, polysaccharide side chains (the
O-antigen) and lipid A (endotoxin), a glucosamine-based
phospholipid. Lipid A usually interacts with TLR4 in addi-
tion to proteins CD14 and MD-2 to induce a pro-inflam-
matory signal [24]. MD-2 is a soluble molecule that is
associated with the extracellular domain of TLR4 and is
generally regarded as essential for LPS recognition by
TLR4 [25-28]. Both TLR2 and TLR4 are therefore likely to
initiate host defense signaling against Bp, a Gram-negative
pathogen.
As expected, our gain-of-function studies using murine
and human constructs confirm a role for TLR2, in con-
junction with TLR1 or TLR6, in initiating inflammatory
signaling in response to heat-killed Bp. As TLR2 forms het-
erodimers with TLR1 or TLR6, the signal detected after
transfection of TLR2 alone is likely explained by low level
endogenous expression of TLR1 in HEK293 cells [22,29].
The role of TLR1 in facilitating TLR2-mediated NF-κB acti-
vation in response to Bp is further elucidated by our obser-
vation of minimal augmentation of the TLR2-dependent
signal when we transfected a known hypo-responding var-
iant human TLR1 plasmid [17].
We also show that heat-killed Bp reliably signals via TLR4
and that Bp  LPS isolated from two separate bacterial
strains activates NF-κB in a uniquely TLR4-mediated fash-BMC Immunology 2008, 9:46 http://www.biomedcentral.com/1471-2172/9/46
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B. pseudomallei LPS signals via TLR4 Figure 2
B. pseudomallei LPS signals via TLR4. HEK293 cells were transiently transfected with (A) murine or (B) human TLR2, 
TLR2/1, TLR2/6, or TLR4; co-receptors CD14 and MD-2; and NF-κB-dependent firefly ELAM luciferase and control β-actin-
dependent Renilla luciferase. In (C) HEK293 cells were transiently transfected with human TLR4 and co-receptor CD14 with 
or without MD-2; and firefly ELAM and Renilla luciferases. Cells were stimulated with media alone, (A & B) Pam3CSK4 1000 
ng/mL, E. coli 0111:B4 LPS 10 ng/mL, BP-1 LPS 10 ng/mL, K96243 LPS 10 ng/mL, or BP-1 lipid A 10 ng/mL. NF-κB activation was 
measured by light emission (relative light units). In (A&B) data plotted are means ± standard deviations of duplicate or tripli-
cate conditions. In (C) the means ± standard deviations of triplicate human TLR4-mediated relative light units (normalized to 
mean empty vector values) are plotted from parallel experiments with or without co-transfection of MD-2. For (A & B) § indi-
cates p < 0.001 compared with empty vector stimulated with the same ligand, and † indicates p < 0.001 compared with TLR2 
stimulated with the same ligand using analysis of variance followed by the Bonferroni post-test. Other comparisons are not 
shown for clarity. Each graph represents one of two independently performed experiments.
Media
Pam3CSK4
Ec LPS
BP-1 LPS
K96243 LPS
BP-1 lipid A
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Empty vector
muTLR2
muTLR2/1
muTLR2/6
muTLR4
+muCD14, muMD-2
§
†
§ §
§
§
§
†
§
R
e
l
a
t
i
v
e
 
L
i
g
h
t
 
U
n
i
t
s A
B
Media
Pam3CSK4
Ec LPS
BP-1 LPS
K96243 LPS
BP-1 lipid A
0.0
0.2
0.4
0.6
0.8
1.0
Emptyv ector
huTLR2
huTLR2/1
huTLR2/6
huTLR4
+huCD14, huMD-2
§
†
§
§
§
§
§
†
§
§
R
e
l
a
t
i
v
e
 
L
i
g
h
t
 
U
n
i
t
s
Media
Ec LPS
BP-1 LPS
K96243 LPS
BP-1 lipid A
0
20
40
60
80
100
120 +huCD14, huMD-2
+huCD14
N
o
r
m
a
l
i
z
e
d
 
h
u
T
L
R
4
-
m
e
d
i
a
t
e
d
 
R
L
U CBMC Immunology 2008, 9:46 http://www.biomedcentral.com/1471-2172/9/46
Page 7 of 10
(page number not for citation purposes)
Figure 3
Absence of TLR4, but not TLR2, impairs the macrophage cytokine response to B. pseudomallei. Bone marrow 
harvested from wild type, TLR2-/-, TLR4-/-, or TLR2/4-/- mice was cultured in the presence of L929 cell conditioned media for 
5–10 days to promote differentiation of macrophages before plating and stimulating with media alone, Pam3CSK4 1000 ng/mL, 
E. coli 0111:B4 LPS 100 ng/mL, heat-killed BP-1 at a bacteria to cell ratio of 100, BP-1 LPS 1000 ng/mL, K96243 LPS 1000 ng/mL, 
or BP-1 lipid A 1000 ng/mL. Supernatants were harvested after 24 hours and (A) TNF-α or (B) IL-10 production was meas-
ured by ELISA. Data plotted are means ± standard deviations of quadruplicate samples. * indicates p < 0.05 and § indicates p = 
0.001 compared with wild type cells stimulated with the same ligand, using analysis of variance followed by the Bonferroni post-
test. Other comparisons are not shown for clarity. The TNF-α data displayed are from one of six independently performed 
experiments stimulating various combinations of wild type, TLR2-/-, TLR4-/-, or TLR2/4-/- macrophages with these ligands, and 
measuring TNF-α. In one of three experiments comparing cytokine responses from TLR2-/- macrophages to wild type macro-
phages, production of TNF-α in response to heat-killed Bp was not significantly increased. The IL-10 data displayed are from 
one of five independently performed experiments stimulating various combinations of wild type, TLR2-/-, TLR4-/-, or TLR2/4-/- 
macrophages with these ligands, and measuring IL-10. In two of three experiments comparing cytokine responses from TLR2-/- 
macrophages to wild type macrophages, production of IL-10 in response to heat-killed Bp was not significantly increased.
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ion. We further demonstrate that Bp LPS subcomponent
lipid A is a TLR4 ligand in cells transfected with either
human or murine TLR constructs. Our observations that
Bp LPS and lipid A are TLR4 ligands differ from the results
of Wiersinga et al. [10], who used HEK293 cells stably
transfected with TLR2/CD14 or TLR4/CD14 to show that
Bp LPS signals through TLR2 but not TLR4. These differ-
ences may be explained by our co-transfection of MD-2, a
molecule that is not endogenously expressed by HEK293
cells [29], but that we demonstrate is essential for TLR4-
dependent signaling in response to Bp, Bp LPS, or Bp lipid
A. While the LPS of a several bacteria signal via TLR2
rather than TLR4 [30-33], some LPS preparations that
appear to stimulate TLR2 may be contaminated with
lipopeptides [34]. Alternatively, there may be strain-spe-
cific differences in Bp LPS structure that influence recogni-
tion by TLR2 and TLR4. Although our results indicating
roles for TLR2 and TLR4 in this gain-of-function system
used heat-killed Bp, they corroborate recent work with live
Bp by others [35].
Our studies using primary murine cells provide additional
evidence that Bp induces a TLR4-mediated inflammatory
cytokine response and that Bp LPS and lipid A are TLR4
ligands. We demonstrate augmented Bp-induced TNF-α
production in the absence of TLR2 alone and in the con-
temporaneous absence of TLR4. This differs from the
TLR2-dependent TNF-α production by alveolar macro-
phages or whole blood stimulated with Bp by Wiersinga et
al. [10] and may be attributable to the different cell types
or bacterial strains used. However, our observations of
enhanced cytokine production support their findings of
reduced bacterial loads and improved survival in respira-
tory infection in TLR2-/- mice compared to wild type mice.
We also observed consistent augmentation in cytokine
production in TLR2-/- macrophages compared to wild type
macrophages upon stimulation with Bp  LPS or with
ultrapure E. coli LPS, the control ligand. We have observed
this phenomenon in previous studies of intracellular TNF-
α production by primary bone marrow cells stimulated
with  Salmonella minnesota Re595 LPS, including in the
absence of differential TLR7-dependent signaling between
wild type and TLR2-/- cells [7]. Others have described a
role for TLR2 agonists in suppressing TLR4-mediated
inflammatory cytokine production [18] and a role for
TLR4 in contributing to pulmonary inflammation in
response to the TLR2 ligand lipoteichoic acid [36]. There
are also other examples of cooperative TLR2 and TLR4 sig-
naling in host defense [37,38]. However, we are not aware
of specific descriptions of the absence of TLR2 influencing
the inflammatory response to TLR4-specific stimulation
alone. The mechanisms underlying this amplifying effect
of TLR2 deficiency upon TLR4-mediated cytokine produc-
tion by Bp  LPS are unclear. If the presence of TLR2 is
indeed suppressive, our data using LPS suggests that mere
expression of the receptor rather than activation may be
adequate to modify TLR4-specific signaling. Other reports
indicate that TLR2 stimulation may induce production of
the anti-inflammatory cytokine IL-10, promoting a Th2-
type response [18,39-42]. However, our data do not sup-
port this mechanism of TLR2-mediated pro-inflammatory
cytokine suppression. To the contrary, we show that Bp
LPS-induced IL-10 production is augmented in the
absence of TLR2, and, despite some differences largely
attributable to experimental variability, generally mirrors
the pattern of pro-inflammatory cytokine release
observed. It may be that in the absence of TLR2, shared
signaling molecules are more available to enhance activa-
tion of other TLRs, including TLR4. Further investigation
will be required to elucidate the interaction of TLR2 and
TLR4 in mediating recognition of Bp.
Both TLR2 and TLR4 signal via the adaptor molecule
MyD88, although TLR4 may also signal in a MyD88-inde-
pendent fashion via adaptor molecule TIR-domain-con-
taining adapter-inducing interferon-β (TRIF) [43]. Our
MyD88 regulates TNF-α production by macrophages stimu- lated with B. pseudomallei Figure 4
MyD88 regulates TNF-α production by macrophages 
stimulated with B. pseudomallei. Bone marrow harvested 
from wild type or MyD88-/- mice was cultured in the pres-
ence of L929 cell conditioned media for 5–10 days to pro-
mote differentiation of macrophages before plating and 
stimulating with media alone or heat-killed BP-1 at a bacteria 
to cell ratio of 100. Supernatants were harvested after 24 
hours and TNF-α production was measured by ELISA. Data 
plotted are means ± standard deviations of quadruplicate 
samples. § indicates p < 0.001 compared with wild type cells, 
using the t test. The data displayed represent one of two 
independently performed experiments.
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observations that pro-inflammatory cytokine production
by heat-killed Bp is largely abolished in the absence of
MyD88 whereas TLR2/4-/- cells demonstrate only partial
impairment in TNF-α release suggest that other MyD88-
dependent receptors may be important in host recogni-
tion of Bp. Specifically, TLR5 and TLR9, receptors that rec-
ognize bacterial flagellin and CpG DNA, respectively, may
account for some of this residual MyD88-dependent
response. TRIF-mediated TLR4 signaling may also play a
role in the innate immune response to Bp infection. These
additional host defense pathways require further study.
Importantly, our experiments have used only heat-killed
Bp and we cannot discount differential signaling induced
by live Bp. Thus, additional investigations with live bacte-
ria are warranted.
Our experiments also indicate that Bp  LPS is a weaker
inducer of TNF-α production in bone marrow-derived
macrophages than E. coli LPS. Others have shown that Bp
LPS is poorly pyrogenic but more mitogenic compared to
Salmonella abortus equi [44]. Bp LPS may contribute to bac-
terial pathogenesis by modulating the host response and
inhibiting macrophage killing [45]. Although Bp LPS is
antigenically indistinguishable from the less virulent
organism  Burkholderia thailandensis [46], we have
observed that Bp LPS may be a stronger inducer of pro-
inflammatory cytokine production in macrophages than
B. thailandensis LPS (unpublished data). Structural analy-
sis of LPS preparations from these Burkholderia strains is
required.
Conclusion
Bp activates TLR2 and TLR4. In the presence of MD-2, Bp
LPS and lipid A are TLR4 ligands. Although the macro-
phage cytokine response to Bp LPS or lipid A is completely
dependent on TLR4, in TLR2-/- macrophages stimulated
with Bp, Bp LPS or lipid A, cytokine production is aug-
mented. Other MyD88-dependent signaling pathways
may also be important in the host response to Bp infec-
tion. These findings provide new insights into critical
mechanisms of host defense in melioidosis.
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